Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name TUG1
   Synonyms TUG1, LINC00080, NCRNA00080, TI-227H, FLJ20618
   Region GRCh38_22:30969245-30979395    Sequence
   Ensembl ENSG00000253352
   RefSeq NR_002323
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name small cell lung cancer
   ICD-0-3 C56.9  M8441/3
   Methods qPCR, RNAi, Western blot, RIP, ChIP, Flow cytometry assay, Cell migration and invasion assay etc.
   Sample SCLC tissues, cell line (NCI-H69, NCI-H446, NCI-H69AR)
   Expression Pattern up-regulated
   Function Description

We found that TUG1 was overexpressed in SCLC tissues. Moreover, downregulation of TUG1 expression could impair cell proliferation and increased cell sensitivity to anticancer drugs both in vitro and in vivo. We also discovered that TUG1 knockdown significantly promoted cell apoptosis and cell cycle arrest, and inhibited cell migration and invasion in vitro. We further demonstrated that TUG1 can regulate the expression of LIMK2b via binding with enhancer of zeste homolog 2 (EZH2), and then promoted cell growth and chemoresistance of SCLC.

   Pubmed ID 28069000
   Year 2017
   Title Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2.
   External Links
   Links for  TUG1 GenBank       HGNC       lncrnadb       Noncode
   Links for  small cell lung cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.